Current paradigms in epigenetic anticancer therapeutics and future challenges.
Singh M, Kumar V, Sehrawat N, Yadav M, Chaudhary M, Upadhyay SK, Kumar S, Sharma V, Kumar S, Dilbaghi N, Sharma AK.
Singh M, et al.
Semin Cancer Biol. 2022 Aug;83:422-440. doi: 10.1016/j.semcancer.2021.03.013. Epub 2021 Mar 22.
Semin Cancer Biol. 2022.
PMID: 33766649
Review.